Josh Enomoto

Josh Enomoto

InvestorPlace Contributor

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

7 Sin Stocks That Can Weather a Recessionary Storm

By Josh Enomoto, InvestorPlace Contributor

While boring might be best during a possible economic downturn, these sin stocks provide a tempting alternative to your portfolio.

7 Short-Squeeze Stocks for Bold Contrarians to Consider

By Josh Enomoto, InvestorPlace Contributor

While market volatility has brough the bears out of hibernation, certain short-squeeze stocks could be a trap for the pessimists.

7 Utility Stocks to Buy Heading Into December 2022

By Josh Enomoto, InvestorPlace Contributor

With possibly choppy waters ahead in the global economy, investors may want to seek shelter in utility stocks to buy.

7 Millionaire-Maker Tech Stocks You Will Regret Not Buying This Year

By Josh Enomoto, InvestorPlace Contributor

While macroeconomic pressures hurt the innovation sector, it also opened doors for millionaire-maker tech stocks to buy.

Why Is Iveric Bio (ISEE) Stock Up 25% Today?

By Josh Enomoto, InvestorPlace Contributor

Biotechnology firm Iveric Bio shot up on a regulatory green light for its key therapeutic, sparking interest in high-risker play ISEE stock.

Load More